Alkermes PLC (ALKS) Receives "Neutral" Rating from Cantor Fitzgerald

Alkermes PLC (ALKS) Receives "Neutral" Rating from Cantor Fitzgerald


's stock had its "neutral" rating restated by analysts at Cantor Fitzgerald in a report released on Thursday. They presently have a $51.00 target price on the stock.



from Biotech News